Heimdall Insights

Global Primary Immunodeficiency Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Primary Immunodeficiency Therapeutics Market was valued at $9.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.8% CAGR, to an estimated market size of $13.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Global Primary Immunodeficiency (PID) Therapeutics Market includes the research, development, and commercialization of pharmaceutical treatments for over 450 rare, congenital disorders where the immune system is missing or dysfunctional. The scope encompasses immunoglobulin replacement therapies (IVIG and SCIG), gene therapies, hematopoietic stem cell transplants, and supportive treatments like antibiotics and targeted biologics, while excluding diagnostics-only services.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Primary Immunodeficiency Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Immunoglobulin Replacement Therapy
  • Gene Therapy
  • Stem Cell & Bone Marrow Transplant
  • Antibiotics & Other Biologics